Investors should be selective in exports, financials, and midcaps. Textiles, pharmaceuticals, and IT offer potential. Private and PSU banks show promise with credit growth. Midcaps and smallcaps are showing earnings recovery. Festive season demand is expected to boost future performance. Opportunities exist for long-term investors.
Laurus Labs shares rally over 4% as Q1FY27 profit jumps 126% on strong CDMO growth
Laurus Labs reported a strong June-quarter performance, with net profit more than doubling and revenue rising 29% year-on-year, driven by robust growth in its CDMO